EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Multizentrische StudieRandomisierte kontrollierte Studie

SafeHeal Colovac Colorectal Anastomosis Protection Device evaluation ( SAFE ‐2) pivotal study: an international randomized controlled study to evaluate the safety and effectiveness of the Colovac Colorectal Anastomosis Protection Device

Elisabeth Hain, Jérémie H Lefèvre iD, Alison Ricardo, Sang Lee, Karen Zaghiyan, Elisabeth McLemore, Danny Sherwinter, Rebecca Rhee, Matthew Wilson iD, Joseph Martz, Justin Maykel, John Marks und 10 weitere

Colorectal Disease · 2024

DOI: 10.1111/codi.17012 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift Colorectal Disease, 2024. Verfasst von Elisabeth Hain und 21 weiteren Autor:innen. Beteiligte Einrichtung: Division of Colon and Rectal Surgery, Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Anastomosis, Surgical, Anastomotic Leak, Colon, Rectal Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Although proximal faecal diversion is standard of care to protect patients with high‐risk colorectal anastomoses against septic complications of anastomotic leakage, it is associated with significant morbidity. The Colovac device (CD) is an intraluminal bypass device intended to avoid stoma creation in patients undergoing low anterior resection. A preliminary study (SAFE‐1) completed in three European centres demonstrated 100% protection of colorectal anastomoses in 15 patients, as evidenced by the absence of faeces below the CD. This phase III trial (SAFE‐2) aims to evaluate the safety and effectiveness of the CD in a larger cohort of patients undergoing curative rectal cancer resection.

Methods

SAFE‐2 is a pivotal, multicentre, prospective, open‐label, randomized, controlled trial. Patients will be randomized in a 1:1 ratio to either the CD arm or the diverting loop ileostomy arm, with a recruitment target of 342 patients. The co‐primary endpoints are the occurrence of major postoperative complications within 12 months of index surgery and the effectiveness of the CD in reducing stoma creation rates. Data regarding quality of life and patient's acceptance and tolerance of the device will be collected.

Discussion

SAFE‐2 is a multicentre randomized, control trial assessing the efficacy and the safety of the CD in protecting low colorectal anastomoses created during oncological resection relative to standard diverting loop ileostomy.

Trial registration

NCT05010850.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anastomosis, SurgicalAnastomotic LeakColonRectal NeoplasmsRectumAdultAgedFemaleHumansMaleMiddle AgedIleostomyPostoperative ComplicationsProctectomyProspective StudiesQuality of LifeTreatment Outcome

Stichwörter der Autor:innen

anastomotic leakagebypass devicecolorectal anastomosisdiverting stomaloop ileostomylow anterior resection

Autor:innen und Institutionen

  • Division of Colon and Rectal Surgery, Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Digestive Surgery, Sorbonne University, AP-HP, Hôpital Saint Antoine, Paris, France.
  • Division of Colon and Rectal Surgery, Department of Surgery, University of Southern California, Los Angeles, California, USA.
  • Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Department of Colon and Rectal Surgery, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, USA.
  • Department of Surgery, Maimonides Medical Center, Brooklyn, New York, USA.

ORCID-Profile: Jérémie H Lefèvre, Matthew Wilson, Nicolas De Hous

Zitieren

APA

Hain, E., Lefèvre, J. H., Ricardo, A., Lee, S., Zaghiyan, K., McLemore, E., Sherwinter, D., Rhee, R., Wilson, M., Martz, J., Maykel, J., Marks, J., Marcet, J., Rouanet, P., Maggiori, L., Komen, N., De Hous, N., Lakkis, Z., Tuech, J. J., …, & Sylla, P. (2024). SafeHeal Colovac Colorectal Anastomosis Protection Device evaluation ( SAFE ‐2) pivotal study: an international randomized controlled study to evaluate the safety and effectiveness of the Colovac Colorectal Anastomosis Protection Device. Colorectal Disease. https://doi.org/10.1111/codi.17012

Vancouver

Hain E, Lefèvre JH, Ricardo A, Lee S, Zaghiyan K, McLemore E, et al. SafeHeal Colovac Colorectal Anastomosis Protection Device evaluation ( SAFE ‐2) pivotal study: an international randomized controlled study to evaluate the safety and effectiveness of the Colovac Colorectal Anastomosis Protection Device. Colorectal Disease. 2024. doi:10.1111/codi.17012

BibTeX
@article{Hain2024,
  author = {Hain, Elisabeth and Lefèvre, Jérémie H and Ricardo, Alison and Lee, Sang and Zaghiyan, Karen and McLemore, Elisabeth and Sherwinter, Danny and Rhee, Rebecca and Wilson, Matthew and Martz, Joseph and Maykel, Justin and Marks, John and Marcet, Jorge and Rouanet, Philippe and Maggiori, Leon and Komen, Niels and De Hous, Nicolas and Lakkis, Zaher and Tuech, Jean-Jacques and Attiyeh, Fadi and Cotte, Eddy and Sylla, Patricia},
  title = {SafeHeal Colovac Colorectal Anastomosis Protection Device evaluation ( SAFE ‐2) pivotal study: an international randomized controlled study to evaluate the safety and effectiveness of the Colovac Colorectal Anastomosis Protection Device},
  journal = {Colorectal Disease},
  year = {2024},
  doi = {10.1111/codi.17012}
}
Kostenlos starten →